BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16487366)

  • 1. Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology.
    Preusser M; Laggner U; Haberler C; Heinzl H; Budka H; Hainfellner JA
    Histopathology; 2006 Mar; 48(4):438-44. PubMed ID: 16487366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M; Budka H; Rössler K; Hainfellner JA
    Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NeuN expression correlates with reduced mitotic index of neoplastic cells in central neurocytomas.
    Englund C; Alvord EC; Folkerth RD; Silbergeld D; Born DE; Small R; Hevner RF
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):429-38. PubMed ID: 16008827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma.
    Soylemezoglu F; Onder S; Tezel GG; Berker M
    Pathol Res Pract; 2003; 199(7):463-8. PubMed ID: 14521262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
    Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
    Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha(v)beta(3) Integrin in central nervous system tumors.
    Lim M; Guccione S; Haddix T; Sims L; Cheshier S; Chu P; Vogel H; Harsh G
    Hum Pathol; 2005 Jun; 36(6):665-9. PubMed ID: 16021573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value and limits of immunohistochemistry in differential diagnosis of clear cell primary brain tumors.
    Koperek O; Gelpi E; Birner P; Haberler C; Budka H; Hainfellner JA
    Acta Neuropathol; 2004 Jul; 108(1):24-30. PubMed ID: 15108012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of oligodendroglioma with prominent neuronal differentiation.
    Hirose T; Nobusawa S; Nakazato Y; Sasaki A
    Hum Pathol; 2013 Oct; 44(10):2353-9. PubMed ID: 24054724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretagogin expression in tumours of the human brain and its coverings.
    Pipp I; Wagner L; Rössler K; Budka H; Preusser M
    APMIS; 2007 Apr; 115(4):319-26. PubMed ID: 17504298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraventricular neurocytoma in a child mimicking oligodendroglioma: a diagnostic pitfall.
    Limaiem F; Bellil S; Chelly I; Mekni A; Bellil K; Jemel H; Haouet S; Zitouna M; Kchir N
    Pathologica; 2009 Apr; 101(2):105-7. PubMed ID: 19886559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytologic diagnosis of glial tumors of the central nervous system].
    Shakunov AN; Triputin ES
    Arkh Patol; 1987; 49(1):41-6. PubMed ID: 3827633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
    Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioneurocytoma: distinctive variant of central neurocytoma.
    Kurose A; Arai H; Beppu T; Wada T; Sato Y; Kubo Y; Jin R; Ogawa A; Sawai T
    Pathol Int; 2007 Dec; 57(12):799-803. PubMed ID: 17988282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
    You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
    J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
    Suri VS; Tatke M; Singh D; Sharma A
    Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-pathological analysis of pilocytic astrocytomas and gangliogliomas.
    Fiks T; Jesionek-Kupnicka D; Zakrzewski K; Polis L; Liberski PP
    Pol J Pathol; 2001; 52(1-2):47-51. PubMed ID: 11505680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.